1-4 of 4
Stuart C. Williamson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3008: The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer

Free
Valentina Cutano, Ming Li Chia, Eleanor M. Wigmore, Stuart C. Williamson, Amanda L. Christie, Brandon Willis, James Kerr, Sophie D’Arcy, Lauren Bradshaw, Cath Eberlein, Lambert Montava Garriga, Elza de Bruin, Susan E. Critchlow, Kevin M. Brindle, Simon T Barry, Susana Ros
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 3008.
https://doi.org/10.1158/1538-7445.AM2025-3008
Published: 21 April 2025
View article titled, Abstract 3008: The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer
Journal Articles

The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance

Open Access
Mandy Lawson, Natalie Cureton, Susana Ros, Azadeh Cheraghchi-Bashi, Jelena Urosevic, Sophie D'Arcy, Oona Delpuech, Michelle DuPont, David I. Fisher, Eric T. Gangl, Hilary Lewis, Dawn Trueman, Neha Wali, Stuart C. Williamson, Jennifer Moss, Elodie Montaudon, Heloise Derrien, Elisabetta Marangoni, Ricardo J. Miragaia, Sladjana Gagrica, Pablo Morentin-Gutierrez, Thomas A. Moss, Gareth Maglennon, Daniel Sutton, Radoslaw Polanski, Alan Rosen, Jonathan Cairns, Pei Zhang, Mònica Sánchez-Guixé, Violeta Serra, Susan E. Critchlow, James S. Scott, Justin P.O. Lindemann, Simon T. Barry, Teresa Klinowska, Christopher J. Morrow, Larissa S. Carnevalli
Journal: Cancer Research
Cancer Res (2023) 83 (23): 3989–4004.
https://doi.org/10.1158/0008-5472.CAN-23-0694
Published: 01 December 2023
View article titled, The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance
Open the PDF for The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance in another window
Includes: Supplementary data
Journal Articles

Abstract 2653: Lineage plasticity in small cell lung cancer generates non- neuroendocrine cells primed for vascular mimicry

Free
Sarah M. Pearsall, Stuart C. Williamson, Fernando García Marqués, Sam Humphrey, Ellyn Hughes, Ian Cannell, Kristopher K. Frese, Melanie Galvin, Mathew Carter, Lynsey Priest, Alastair Kerr, Martin J. Humphries, Jonathon D. Humphries, Fiona Blackhall, Gregory Hannon, Julien Sage, Sharon J. Pitteri, Kathryn L. Simpson, Caroline Dive
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2653.
https://doi.org/10.1158/1538-7445.AM2021-2653
Published: 01 July 2021
View article titled, Abstract 2653: Lineage plasticity in small cell lung cancer generates non- neuroendocrine cells primed for vascular mimicry
Journal Articles

The MEK5–ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer

Free
Sandra Cristea, Garry L. Coles, Daniel Hornburg, Maya Gershkovitz, Julia Arand, Siqi Cao, Triparna Sen, Stuart C. Williamson, Jun W. Kim, Alexandros P. Drainas, Andrew He, Laurent Le Cam, Lauren Averett Byers, Michael P. Snyder, Kévin Contrepois, Julien Sage
Journal: Cancer Research
Series: Author Choice
Cancer Res (2020) 80 (6): 1293–1303.
https://doi.org/10.1158/0008-5472.CAN-19-1027
Published: 13 March 2020
View article titled, The MEK5–ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer
Open the PDF for The MEK5–ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer in another window
Includes: Supplementary data